Zinbryta Multiple Sclerosis Injection Drug Lawsuit

Zinbryta Multiple Sclerosis Injection Drug LawsuitPlease pay attention to and notify loved ones with multiple sclerosis about this very important news for multiple sclerosis patients who have been treated with the injection drug Zinbryta (daclizumab): as of March 2018, a worldwide voluntary recall of Zinbryta by the drug manufacturers is now in effect. There have been at least three deaths in the United States related to brain problems due to use of the drug. Zinbryta has been associated with least 12 reported cases of the dangerous brain inflammation disorders encephalitis and meningoencephalitis.

If you or a loved one has used Zinbryta, it is recommended you consult with your doctor immediately regarding the medication. You may be entitled to compensation for pain and suffering due to using the drug. Please contact the Pittman, Dutton, Hellums, Bradley & Mann team of pharmaceutical litigation attorneys as soon as possible. We provide free consultations and can help you or a loved one recover damages for this dangerous product.

Latest Known Facts:

  • Zinbryta was introduced in 2016
  • The drug was used for the treatment of adult patients with relapsing forms of multiple scelrosis
  • Zinbryta side effects have included liver injury risk
  • Because of possible side effects, Zinbryta was only available through a Risk Evaluation and Mitigation Strategy program in the U.S.
  • Zinbryta was only recommended to patients who failed to respond to other multiple sclerosis treatments
  • More than 8,000 patients worldwide have received Zinbryta
  • Several ongoing clinical studies for Zinbryta have been halted

Zinbryta’s Treatment Effects

Zinbryta Multiple Sclerosis Injection Drug LawsuitThe brain inflammation cases that are now emerging are just the latest in problems that have affected Zinbryta patients. In November 2017, the European Medicines Agency (EMA) announced a restriction of the drug to the risk of severe liver damage.

In Europe, like the U.S., treatment involving Zinbryta was restricted. Only European patients who had tried at least two other treatments would be able to use it, and it was not able to be used with any other treatment for multiple sclerosis. Zinbryta was available to patients in the European Union, the U.S., Switzerland, Canada and Australia.

In February 2018, a review of Zinbryta was requested from the European Commission. Upon its review and because of the prevalence of danger treatment patients have experienced, the manufacturing companies Biogen and AbbVie withdrew the drug.

Currently, the U.S. Food and Drug Administration is working to organize a full withdrawal of the drug from the U.S. and to educate physicians about how to transition patients who have been using Zinbryta. The drug will only be available until April 30, 2018.

Warning Signs of Harmful Zinbryta Effects

Encephalitis and meningoencephalitis are brain disorders that can cause serious side effects and potentially death.

Warning signs of encephalitis include:

Flu-like symptoms, including headache, fever, muscle or joint aching, and fatigue or weakness

Confusion or hallucinations


Paralysis in face or body

Muscle weakness

Loss of consciousness

Warning signs of meningoencephalitis include:

Sudden high fever

Stiff neck

Severe headache



Loss of appetite or thirst

Anyone who has taken Zinbryta, after consulting with their physician, should be vigilant of warning signs like these, as well as any health conditions that are out of the ordinary. Contact a physician immediately if you feel like you may be experiencing a sign of brain inflammation. If you have experienced any negative side effects, it’s also vital to contact an attorney who may be able to help you.

Get Help from a Pharmaceutical Litigation Attorney

At Pittman, Dutton, Hellums, Bradley & Mann, we unfortunately know all too well whose best interest is at the heart of many pharmaceutical companies: their own. When you use a prescription drug, you expect that the drug be thoroughly tested and safe to use. Sadly, this is not always the case. Zinbryta and its manufacturers have taken lives of patients and caused irreversible damage. This is unacceptable for patients and their families.

The Pittman, Dutton, Hellums, Bradley & Mann team is here to fight for you. We review your case, help gather evidence, and present your claim so that you achieve the justice and compensation you deserve. We are prepared to take cases to trial and have successfully helped patients from across the country obtain lawfulness due to their pain and suffering. We can help you or a loved one fight pharmaceutical companies that only care about their bottom lines and that employ their own law teams for unfair incidents like these.

Any time you contact us, we offer free, no-obligation consultations. Call (205) 322-8880 to speak with one of our caring representatives, or contact us online. We’ll provide you with more information regarding if we can help you fight for what you deserve.